Jan P. Arends

3.8k total citations
40 papers, 2.2k citations indexed

About

Jan P. Arends is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Jan P. Arends has authored 40 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 10 papers in Epidemiology and 9 papers in Molecular Biology. Recurrent topics in Jan P. Arends's work include Antimicrobial Resistance in Staphylococcus (14 papers), Antibiotic Resistance in Bacteria (8 papers) and Bacterial biofilms and quorum sensing (8 papers). Jan P. Arends is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (14 papers), Antibiotic Resistance in Bacteria (8 papers) and Bacterial biofilms and quorum sensing (8 papers). Jan P. Arends collaborates with scholars based in Netherlands, Germany and Czechia. Jan P. Arends's co-authors include H. C. Zanen, Susanne Engelmann, Hermie J. M. Harmsen, Michael Hecker, Mark J. J. B. Sibbald, Anne‐Kathrin Ziebandt, Greetje A. Kampinga, Paul E. Verweij, Jan W. M. van der Linden and John W. A. Rossen and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and Microbiology and Molecular Biology Reviews.

In The Last Decade

Jan P. Arends

40 papers receiving 2.1k citations

Peers

Countries citing papers authored by Jan P. Arends

Since Specialization

Citations

This map shows the geographic impact of Jan P. Arends's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan P. Arends with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan P. Arends more than expected).

Fields of papers citing papers by Jan P. Arends

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan P. Arends. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan P. Arends. The network helps show where Jan P. Arends may publish in the future.

Co-authorship network of co-authors of Jan P. Arends

This figure shows the co-authorship network connecting the top 25 collaborators of Jan P. Arends. A scholar is included among the top collaborators of Jan P. Arends based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan P. Arends. Jan P. Arends is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Defining Multidrug Resistance of Gram-Negative Bacteria in the Dutch–German Border Region—Impact of National Guidelines 2018 ·Microorganisms ·Robin Köck, (unknown), (unknown), Stefanie Kampmeier, (unknown), Corinna Glasner, Jan P. Arends, Karsten Becker, Alexander W. Friedrich	12
2	Elucidating vancomycin-resistant Enterococcus faecium outbreaks: the role of clonal spread and movement of mobile genetic elements 2018 ·Journal of Antimicrobial Chemotherapy ·(unknown), Monika A. Chlebowicz, Erik Bathoorn, Sigrid Rosema, Natacha Couto, Mariëtte Lokate, Jan P. Arends, Alex W. Friedrich, John W. A. Rossen	31
3	Genetic loci of Staphylococcus aureus associated with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides 2017 ·Scientific Reports ·Corinna Glasner, Marcus C. de Goffau, Mirjan M. van Timmeren, Mirja L. Schulze, (unknown), Mehri Tavakol, Willem J. B. van Wamel, Coen A. Stegeman, Cees G. M. Kallenberg, Jan P. Arends, John W. A. Rossen, Peter Heeringa, Jan Maarten van Dijl	21
4	Epidemiology of Extended-Spectrum β-Lactamase-Producing E. coli and Vancomycin-Resistant Enterococci in the Northern Dutch–German Cross-Border Region 2017 ·Frontiers in Microbiology ·(unknown), Silvia García-Cobos, G J H M Ruijs, Greetje A. Kampinga, Jan P. Arends, (unknown), L V Möller, (unknown), Theo A. Schuurs, (unknown), Jan Weel, Jan H. van Zeijl, Robin Köck, John W. A. Rossen, Alexander W. Friedrich	25
5	Low anti-staphylococcal IgG responses in granulomatosis with polyangiitis patients despite long-term Staphylococcus aureus exposure 2015 ·Scientific Reports ·Corinna Glasner, Mirjan M. van Timmeren, (unknown), Till F. Omansen, Erwin C. Raangs, John W. A. Rossen, Marcus C. de Goffau, Jan P. Arends, Greetje A. Kampinga, (unknown), Jolanda Neef, Girbe Buist, Mehri Tavakol, Willem J. B. van Wamel, Abraham Rutgers, Coen A. Stegeman, Cees G. M. Kallenberg, Peter Heeringa, Jan Maarten van Dijl	20
6	Burden of highly resistant microorganisms in a Dutch intensive care unit. 2015 ·PubMed ·(unknown), Jan P. Arends, (unknown), Jan G. Zijlstra	5
7	Staphylococcus aureus spa type t437: identification of the most dominant community-associated clone from Asia across Europe 2014 ·Clinical Microbiology and Infection ·Corinna Glasner, Gerlinde Pluister, Henrik Westh, Jan P. Arends, Joanna Empel, Elizabeth Giles, Frédéric Laurent, Franziska Layer, (unknown), Andreas Matussek, Alexander Mellmann, (unknown), Erika Ungvári, Xiaomei Yan, Helena Žemličková, Hajo Grundmann, Jan Maarten van Dijl	25
8	Algorithm for pre-emptive glycopeptide treatment in patients with haematologic malignancies and an Enterococcus faecium bloodstream infection 2013 ·Antimicrobial Resistance and Infection Control ·(unknown), Jan P. Arends, Lambert F. R. Span, Alexander W. Friedrich	6
9	Latent introduction to the Netherlands of multiple antibiotic resistance including NDM-1 after hospitalisation in Egypt, August 2013 2013 ·Eurosurveillance ·Erik Bathoorn, Alex W. Friedrich, Kai Zhou, Jan P. Arends, (unknown), Hajo Grundmann, John W. A. Rossen	25
10	Diagnosis and antimicrobial therapy of Mycoplasma hominis meningitis in adults 2012 ·International Journal of Medical Microbiology ·(unknown), (unknown), Jan Maarten van Dijl, (unknown), Jan P. Arends	18
11	Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study 2011 ·The Lancet Infectious Diseases ·Anne Marie G. A. de Smet, Jan Kluytmans, Hetty E. M. Blok, Ellen M. Mascini, Robin F. J. Benus, A.T. Bernards, Ed J. Kuijper, Maurine A. Leverstein‐van Hall, A Jansz, Bartelt M. de Jongh, G. J. van Asselt, Ine Frénay, Steven Thijsen, (unknown), J A Kaan, Jan P. Arends, Patrick Sturm, Martin Bootsma, Marc JM Bonten	112
12	Proteomics uncovers extreme heterogeneity in the Staphylococcus aureus exoproteome due to genomic plasticity and variant gene regulation 2010 ·PROTEOMICS ·Anne‐Kathrin Ziebandt, Harald Kusch, (unknown), (unknown), Mark J. J. B. Sibbald, Jan P. Arends, Monika A. Chlebowicz, Dirk Albrecht, Roman Pantůček, Jiřı́ Doškař, Wilma Ziebuhr, Barbara M. Bröker, Michael Hecker, Jan Maarten van Dijl, Susanne Engelmann	132
13	Is bacteriologic surveillance in endoscope reprocessing stringent enough? 2009 ·Endoscopy ·Julia Kovaleva, N.E.L. Meessen, Femke P. Peters, Martin Been, Jan P. Arends, (unknown), J. E. Degener	61
14	PANTOEA AGGLOMERANS SEPTICEMIA IN THREE NEWBORN INFANTS 2007 ·The Pediatric Infectious Disease Journal ·(unknown), Jan P. Arends, Elisabeth H. Schölvinck	36
15	Spread of a methicillin-resistant Staphylococcus aureus ST80 strain in the community of the northern Netherlands 2007 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), (unknown), (unknown), Jan P. Arends, A. Möller	31
16	Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999–2001 2006 ·Clinical Microbiology and Infection ·P.J. van den Broek, Jan P. Arends, A.T. Bernards, (unknown), Ellen M. Mascini, T. J. K. van der Reijden, Lodewijk Spanjaard, (unknown), Anneke van der Zee, Jan H. van Zeijl, Lenie Dijkshoorn	59
17	Outbreak ofSerratia marcescensColonization and Infection Traced to a Healthcare Worker With Long-Term Carriage on the Hands 2006 ·Infection Control and Hospital Epidemiology ·Jutte J.C. de Vries, (unknown), (unknown), (unknown), John E. Degener, Jan P. Arends	45
18	Occurrence of Extended-Spectrum Betalactamases (ESBL) in Dutch Hospitals 1999 ·Infection ·Ellen E. Stobberingh, Jan P. Arends, (unknown), Wil H. F. Goessens, (unknown), A. G. M. Buiting, Y. J. Debets-Ossenkopp, R J van Ketel, M L van Ogtrop, L. Sabbe, G. Paul Voorn, (unknown), Jan H. van Zeijl	39
19	Differences in virulence between two strains of Streptococcus suis type II after experimentally induced infection of newborn germ-free pigs 1989 ·American Journal of Veterinary Research ·U. Vecht, Jan P. Arends, E. J. van der Molen, L.A.M.G. van Leengoed	104
20	Meningitis Caused by Streptococcus suis in Humans 1988 ·Clinical Infectious Diseases ·Jan P. Arends, H. C. Zanen	368

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact